ALT Bioscience logo

ALT Bioscience

Advancing diagnostic and biomedical technologies to enhance oral-systemic health and combat neurodegenerative diseases.

VS
Magnisense logo

Magnisense

Creating rapid diagnostic solutions for cardiovascular illnesses through proprietary MIAtek® technology and advanced diagnostic instruments

Side-by-Side Comparison

Metric ALT Bioscience Magnisense
Founded 1997 2003
Headquarters Not tracked yet Not tracked yet
Employees Not tracked yet 1
Industry Biotechnology, Life Sciences, Pharmaceutical Health Care
Funding Stage Series Unknown Series Unknown
Total Funding $8.15M $11.70M
Funding Rounds 3 3
Business Model Not tracked yet Not tracked yet
Revenue Model Not tracked yet Not tracked yet
Services Not tracked yet Not tracked yet
Target Customers Not tracked yet Not tracked yet
Taxonomy Bioscience, Diagnostic Technologies, Biomedical Technologies, Oral-systemic Health, Neurodegenerative Diseases, Research And Development, Commercialization, Life Sciences, Kentucky, Innovations Cardiovascular Diagnostics, Emergency Diagnostics, MIAtek® Technology, Proprietary Diagnostic Instruments, Rapid Diagnostics, Diagnostic Tests, Cardiovascular Diseases, Innovation, Healthcare Solutions
Website perio-dx.com magnisense.com
ALT Bioscience logo

About ALT Bioscience

ALT Bioscience is a biotechnology and pharmaceutical company that was founded in 1997 with a mission to advance diagnostic and biomedical technologies. Headquartered in Lexington, Kentucky, the company is dedicated to enhancing oral-systemic health and combatting neurodegenerative diseases. Their sl...

Magnisense logo

About Magnisense

Magnisense is a health care startup that has been making waves in the industry since its founding in 2003. The company's slogan "Creating rapid diagnostic solutions for cardiovascular illnesses through proprietary MIAtek® technology and advanced diagnostic instruments" embodies its core mission. In...

Frequently Asked Questions

ALT Bioscience — Advancing diagnostic and biomedical technologies to enhance oral-systemic health and combat neurodegenerative diseases.. Magnisense — Creating rapid diagnostic solutions for cardiovascular illnesses through proprietary MIAtek® technology and advanced diagnostic instruments. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
ALT Bioscience has raised $8.15M while Magnisense has raised $11.70M.
ALT Bioscience and Magnisense operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Track both companies in real time

Signal Tracker monitors ALT Bioscience, Magnisense, and millions of companies for 40+ signal types.

Related Comparisons

One analytics cookie (Google Analytics). Cookie Policy